A detailed history of Panagora Asset Management Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 194,172 shares of AXGN stock, worth $2.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
194,172
Previous 292,214 33.55%
Holding current value
$2.81 Million
Previous $2.12 Million 28.7%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.52 - $14.69 $737,275 - $1.44 Million
-98,042 Reduced 33.55%
194,172 $2.72 Million
Q2 2024

Jul 29, 2024

SELL
$5.67 - $8.06 $459,400 - $653,045
-81,023 Reduced 21.71%
292,214 $2.12 Million
Q1 2024

May 07, 2024

BUY
$6.63 - $10.69 $1.38 Million - $2.22 Million
207,776 Added 125.57%
373,237 $3.01 Million
Q4 2023

Feb 08, 2024

BUY
$3.61 - $7.76 $245,483 - $527,687
68,001 Added 69.77%
165,461 $1.13 Million
Q3 2023

Oct 31, 2023

BUY
$4.68 - $9.26 $288,185 - $570,212
61,578 Added 171.61%
97,460 $487,000
Q2 2023

Aug 11, 2023

SELL
$8.5 - $10.38 $197,106 - $240,701
-23,189 Reduced 39.26%
35,882 $327,000
Q1 2023

May 11, 2023

SELL
$7.53 - $10.95 $61,188 - $88,979
-8,126 Reduced 12.09%
59,071 $558,000
Q4 2022

Feb 13, 2023

BUY
$9.44 - $13.09 $483,092 - $669,880
51,175 Added 319.4%
67,197 $670,000
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $31,591 - $47,542
3,881 Added 31.97%
16,022 $191,000
Q2 2022

Aug 15, 2022

BUY
$6.99 - $10.0 $84,865 - $121,410
12,141 New
12,141 $99,000
Q3 2021

Nov 10, 2021

SELL
$15.23 - $21.72 $578 - $825
-38 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$17.8 - $23.5 $676 - $893
38 New
38 $1,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $612M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.